摘要
目的:研究间变性大细胞淋巴瘤(ALCL)的临床病理特点和免疫表型,提高该疾病的早期诊断,并比较ALK+与ALK-在临床表现、治疗和预后的不同点。方法:对原诊断为ALCL的20例病例重新行组织学观察和免疫组织化学染色(ABC法)并复习相关文献。结果:20例中15例属于T/Null细胞表型,结合免疫组化诊断为ALCL,15例ALCL均强烈表达CD30;ALK阳性者9例,ALK的表达与患者性别,免疫分型、组织分型、临床分期无相关性;而与患者年龄及化疗敏感性具有相关性(P<0.05)。其余5例为B细胞表型(CD20强阳性),结合新的淋巴瘤分类标准,被诊断为弥漫性大B细胞淋巴瘤(DLBCL)。结论:间变性大细胞淋巴瘤中具有标志性的大细胞出现CD30、ALK和EMA阳性时,对ALCL的诊断具有重要价值;ALK+ALCL与ALK-ALCL在遗传特征,临床表现及治疗预后的不同,使其作为一种新的病理类型被提出具有合理性。
Objective: To investigate the clinicopathological and immunohistochemical characteristics of anaplastic large cell lymphoma (ALCL) and to compare the differences in clinical manifestation, treatment and prognosis between ALK-positive cases and ALK-negative cases. Methods Histological and immunohistochemical staining methods (ABC method) were used to analyze 20 previously diagnosed cases of ALCL, and the correlated clinical data were reviewed. Results: Fifteen of the 20 cases were T/Null cell type (8 T and 7 Null) and were di- agnosed as ALCL with immunohistochemistry. CD30 was strongly expressed in the 15 cases of ALCL. There were 9 ALK-positive cases. No correlation was found between ALK expression and sex, immunohistochemical type, histological type, or clinical stage. However, a significant correlation was found between ALK expression and age and sensitivity to chemotherapy (P〈0.05). The remaining 5 cases were B cell type, and they were true DLBCL. Conclusion: Our study highlights the importance of histopathological features and the significance of CD30 and ALK in the diagnosis of ALCL. The differences between ALK-positive ALCL and ALK-negative ALCL suggest specific studies on these genes, including differences in clinical manifestation and remission rates after chemotherapy, should be performed.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2008年第15期841-844,共4页
Chinese Journal of Clinical Oncology
基金
天津市科委重大科技攻关项目基金资助(编号:043115211-1)
关键词
淋巴瘤
间变
免疫组织化学
鉴别诊断
Lymphoma
Anaplastic lymphoma kinase
Immunohistochemistry
Differential diagnosis